Plus   Neg

Norsk Hydro Slips To Loss In Q4

Norsk Hydro (NHY,NHYDY.PK,NHYDY.PK) reported that its loss attributable to shareholders for the fourth-quarter was 536 million Norwegian Kroner or 0.26 Kroner per share, compared to net income of 3.50 billion Kroner or 1.71 Kroner per share in the previous year.

Reported EBIT amounted to 335 million Kroner for the fourth quarter 2018, compared to 4.511 billion Kroner in fourth quarter 2017.

Total revenue and income for the quarter dropped to 38.68 billion Kroner from 41.42 billion Kroner last year.

For 2019, the company expects the global primary aluminium market to be in deficit, although increasing macro uncertainty could lead to softening demand growth.

For 2018, Hydro's Board of Directors proposes a dividend of 1.25 Kroner per share, reflecting Hydro's robust financial situation, taking into account a demanding year for the company and the volatility in the aluminium industry. The proposed payment represents a 58% percent pay-out ratio of reported net income for the year and demonstrates the company's commitment to provide a competitive cash return to shareholders. Hydro has a dividend policy of a 40% payout-ratio of reported net income over the cycle, with 1.25 Kroner per share considered as a floor.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Just Egg, a plant-based egg alternative, will be available in 2,100 stores owned by grocery chain Kroger Co. later this month. The product launch comes as plant-based meat and egg alternatives gain traction in the country. Just Egg, a product of California-based food technology company Just Inc., will be available at Kroger-owned stores, including Kroger, Fred Meyer and Ralphs. Boeing has delivered the first 787-10 Dreamliner to Vietnam Airlines, the flag carrier of Vietnam, as part of the eight 787-10 Dreamliner airplanes to be delivered on lease through Air Lease. Vietnam Airlines said the 787-10 Dreamliner, claimed by Boeing to be the most fuel-efficient twin-aisle airplane in the industry, will help it raise the customer experience on the Hanoi to Ho Chi Minh route. The U.S. Food and Drug Administration or FDA announced on its website that pharma major Pfizer, Inc. issued recall of two lots of tablets meant to treat acute migraine in adults for concerns over bacteria infection. The pharma company is recalling two lots of Relpax (eletriptan hydrobromide) 40 mg tablets for potential presence of Genus Pseudomonas and Burkholderia bacteria.
Follow RTT